Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria model

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 50, 2007, Pages 19914-19919

  Wargo, Andrew R ^a,b,c   Huijben, Silvie ^a   De Roode, Jacobus C ^a,d   Shepherd, James ^a   Read, Andrew F ^a,e  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN FISHERIES RESEARCH CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d EMORY UNIVERSITY   (United States)

^e PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Competition; Evolution of drug resistance; In host ecology; Plasmodium chabaudi; Transmission

Indexed keywords

ANTIMALARIAL AGENT; COMPLEMENTARY DNA; PYRIMETHAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPETITION; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE TRANSMISSION; ECOLOGY; ERYTHROCYTE; EVOLUTION; GAMETOCYTE; HOST PARASITE INTERACTION; MALARIA; MORTALITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE; PARASITE VIRULENCE; PLASMODIUM CHABAUDI; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG RESISTANCE; FEMALE; MALARIA; MICE; PLASMODIUM CHABAUDI;

MUS; PLASMODIUM CHABAUDI; RODENTIA;

EID: 38049160116     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0707766104     Document Type: Article

References (58)

1. Attaran A, Barnes KI, Curtis C, D'Alessandro U, Fanello CI, Galinski MR, Kokwaro G, Looareesuwan S, Makanga M, Mutabingwa TK, et al. (2004) Lancet 363:237-240.
2. Hyde JE (2005) Trends Parasitol 21:494-498.
3. Hastings IM, Donnelly MJ (2005) Drug Resist Updat 8:43-50.
4. Hastings IM, D'Alessandro U (2000) Parasitol Today 16:340-347.
5. Hastings IM (2001) Trop Med Int Health 6:883-890.
6. Hastings IM, Watkins WM, White NJ (2002) Phil Trans R Soc London Ser B 357:505-519.
7. O'Meara W, Smith DL, McKenzie FE (2006) PLoS Med, 10.1371/jpmed.0030141.
8. Koella JC, Antia R (2003) Malaria J, 10.1186/1475-2875-1182-1183.
9. Mackinnon M (2005) Acta Trop 94:207-217.
10. Hastings IM (1997) Parasitology 115:133-141.
11. Hastings IM (2003) Trends in Parasitol 19:70-73.
12. Hastings IM (2006) Parasitology 132:615-624.
13. Mackinnon MJ, Hastings IM (1998) Trans R Soc Trop Med Hyg 92:188-195.
14. Lipsitch M, Samore MH (2002) Emerg Infect Dis 8:347-354.
15. Page MGP, Cooper HL, Gross LJ (1994) Science 265:589-591.
16. Goldhaber M (1994) Science 266:1462.
17. Hastings IM, Watkins W (2005) Acta Trop 94:218-229.
18. Awadalla P, Walliker D, Babiker HA, Mackinnon MJ (2001) Trends Parasitol 17:351-353.
19. Anderson TJC, Haubold B, Williams JT, Estrada-Franco JG, Richardson L, Mollinedo R, Bockarie M, Mokili J, Mharakurwa S, French N, et al. (2000) Mol Biol Evol 17:1467-1482.
20. Babiker HA, Ranford-Cartwright LC, Walliker D (1999) Trans R Soc Trop Med Hyg 93:11-14.
21. Jafari S, Le Bras J, Bouchaud O, Durand R (2004) J Infect Dis 189:195-203.
22. Babiker HA, Abdel-Muhsin AA, Hamad A, Mackinnon MJ, Hill WG, Walliker D (2000) Parasitology 120:105-111.
23. Magesa SM, Mdira KY, Babiker HA, Alifrangis M, Farnert A, Simonsen PE, Bygbjerg IC, Walliker D, Jakobsen PH (2002) Acta Trop 84:83-92.
24. Daubersies P, Sallenave-Sales S, Magne S, Trape JF, Contamin H, Fandeur T, Rogier C, Mercereau-Puijalon O, Druilhe P (1996) Am J Trop Med Hyg 54:18-26.
25. Mercereau-Puijalon O (1996) Parasite Immunol 18:173-180.
26. Arnot D (1998) Trans R Soc Trop Med Hyg 92:580-585.
27. Bruce MC, Donnelly CA, Alpers MP, Galinski MR, Barnwell JW, Walliker D, Day KP (2000) Science 287:845-848.
28. Smith TS, Felger I, Tanner M (1997) Trans R S Trop Med Hyg 93:59-64.
29. Talisuna AO, Erhart A, Samarasinghe S, Van Overmeir C, Speybroeck N, D'Alessandro U (2006) Infect Gen Evol 6:241-248.
30. Jarra W, Brown KN (1989) Parasite Immunol 11:1-13.
31. Snounou G, Jarra W, Viriyakosol S, Wood JC, Brown KN (1989) Mol Biochem Parasitol 37:37-46.
32. Taylor LH, Walliker D, Read AF (1997) Proc R Soc London Ser B 264:927-935.
33. de Roode JC, Culleton R, Cheesman SJ, Carter R, Read AF (2004) Proc R Soc London Ser B 271:1073-1080.
34. de Roode JC, Pansini R, Cheesman SJ, Helinski MEH, Huijben S, Wargo AR, Bell AS, Chan BHK, Walliker D, Read AF (2005) Proc Nat Acad Sci USA 102:7624-7628.
35. Bell AS, de Roode JC, Sim D, Read AF (2006) Evolution (Lawrence, Kans) 60:1358-1371.
36. Wargo AR, de Roode JC, Huijben S, Drew DR, Read AF (2007) Proc R Soc London Ser B 274:2629-2638.
37. de Roode JC, Culleton R, Bell AS, Read AF (2004) Malaria J, 10.1186/1475-2875-1183-1133.
38. Cravo PV, Culleton R, Hunt P, Walliker D, Mackinnon M (2001) Antimicrob Agents Chemother 45:2897-2901.
39. Yap GS, Stevenson MM (1994) Infect Immun 62:3761-3765.
40. Hellriegel B (1992) Proc R Soc London Ser B 250:249-256.
41. Råberg L, de Roode JC, Bell AS, Stamou P, Gray D, Read AF (2006) Am Nat 168:41-53.
42. Read AF, Taylor LH (2001) Science 292:1099-1102.
43. Gupta S, Anderson RM (1999) Parasitol Today 15:497-501.
44. Almogy G, Cohen N, Stacker S, Stone L (2002) Proc R Soc London Ser B 269:809-815.
45. Martinelli A, Cheesman SJ, Hunt P, Culleton R, Raza A, Mackinnon M, Carter R (2005) Proc Nat Acad Sci USA 102:814-819.
46. Babiker HA, Lines J, Hill WG, Walliker D (1997) Am J Trop Med Hyg 56:141-147.
47. Mackinnon MJ, Read AF (2004) Phil Trans R Soc London Ser B 359:965-986.
48. Taylor-Robinson A (1995) Parasitol Today 11:334-342.
49. Field JW, Niven IC (1937) Trans R Soc Trop Med Hyg 30:569-574.
50. Collins WE, Jeffery GM (1999) Am J Trop Med Hyg 61:4-19.
51. Mackinnon MJ, Read AF (1999) Evolution (Lawrence, Kans) 53:689-703.
52. Gibbons A, Aldhous P (1992) Science 257:1036-1038.
53. Bloom BR (1992) Nature 358:538-539.
54. Blomberg B, Fourie B (2003) Drugs 63:535-553.
55. Dye C (2002) Science 295:2042-2046.
56. Beale GH, Carter R, Walliker D (1978) in Rodent Malaria, eds Killick-Kendrick R, Peters W (Academic, London), pp 213-245.
57. Walliker D, Hunt P, Babiker HA (2005) Acta Trop 94:251-259.
58. Wargo AR, Randle N, Chan BHK, Thompson J, Read AF, Babiker HA (2006) Exp Parasitol 112:13-20.